A1LWH

Tapinarof

Created:2024-01-16
Last modified:  2025-11-19

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count37
Chiral Atom Count0
Bond Count38
Aromatic Bond Count12
2D diagram of A1LWH
Toggle HydrogenToggle Labels

Chemical Component Summary

NameTapinarof
Synonyms5-[(E)-2-phenylethenyl]-2-propan-2-yl-benzene-1,3-diol; DB06083
Systematic Name (OpenEye OEToolkits)5-[(~{E})-2-phenylethenyl]-2-propan-2-yl-benzene-1,3-diol
FormulaC17 H18 O2
Molecular Weight254.324
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385CC(C)c1c(O)cc(C=Cc2ccccc2)cc1O
SMILESOpenEye OEToolkits2.0.7CC(C)c1c(cc(cc1O)C=Cc2ccccc2)O
Canonical SMILESCACTVS3.385 CC(C)c1c(O)cc(/C=C/c2ccccc2)cc1O
Canonical SMILESOpenEye OEToolkits2.0.7 CC(C)c1c(cc(cc1O)/C=C/c2ccccc2)O
InChIInChI1.06 InChI=1S/C17H18O2/c1-12(2)17-15(18)10-14(11-16(17)19)9-8-13-6-4-3-5-7-13/h3-12,18-19H,1-2H3/b9-8+
InChIKeyInChI1.06 ZISJNXNHJRQYJO-CMDGGOBGSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank IDDB06083 
NameTapinarof
Groups
  • approved
  • investigational
DescriptionTapinarof is a novel, first-in-class, small-molecule AhR agonist that is indicated for the treatment of adult psoriasis. It is available as a topical cream to be applied to the affected area once daily.[L41845, A248790] Tapiranof was first discovered as a metabolite (3,5-dihydroxy-4-isopropylstilbene) produced in _Photorhabdus luminescens_, a gram-negative bacillus that lives symbiotically with the _Heterorhabditis_ nematodes.[A248790] In 1959, it was noticed that _Heterorhabditis_ with a high amount of 3,5-dihydroxy-4-isopropylstilbene did not putrefy once dead, thus suggesting its potential anti-inflammatory activity.[A248790] Tapinarof received initial approval from the FDA in 2022.[L41845]
Synonyms
  • Tapinarof
  • Benvitimod
  • 3,5-Dihydroxy-4-isopropyl-trans-stilbene
Brand NamesVtama
IndicationTapinarof is indicated for the topical treatment of plaque psoriasis in adults.[L41845]
Categories
  • Antipsoriatics
  • Antipsoriatics for Topical Use
  • Aryl Hydrocarbon Receptor Agonist
  • Benzene Derivatives
  • Benzylidene Compounds
ATC-CodeD05AX07
CAS number79338-84-4

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Aryl hydrocarbon receptorMNSSSANITYASRKRRKPVQKTVKPIPAEGIKSNPSKRHRDRLNTELDRL...unknownagonist
Cytochrome P450 1A2MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...unknownsubstrate
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate
Cytochrome P450 2C9MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...unknownsubstrate
Cytochrome P450 2C19MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL259571
PubChem 6439522
ChEMBL CHEMBL259571
ChEBI CHEBI:215747